SAN DIEGO, March 10, 2025 /PRNewswire/ -- Glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as semaglutide (e.g., Ozempic), have helped improve the management of type 2 diabetes and ...
The use of GLP-1s in the perioperative period surrounding major surgeries, such as total joint arthroplasties, is a growing source of concern among orthopedic surgeons. A study presented at the 2025 ...
Medpage Today on MSN
Studies Hint at Potential Negative Effects of GLP-1 Drugs in Orthopedic Patients
SAN DIEGO -- Two retrospective studies hinted at potential negative effects of GLP-1 receptor agonists for patients requiring ...
Patients who continued Ozempic through total joint arthroplasty had the highest risk for complications. HealthDay News — Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days ...
Researchers in Japan conducted a randomized clinical trial in 177 children (age, 1 year to < 6 years; 71% boys) scheduled for elective surgery involving the lower abdomen or extremities to assess ...
These patients were compared to a control group of 206,005 with no history of Ozempic use. The cohorts were analyzed to determine the relationship between the time elapsed from their last Ozempic dose ...
Patients who continued Ozempic through total joint arthroplasty had the highest risk for complications. (HealthDay News) — Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback